
Collective Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.3/10
Best for: the lowest flat medication price if you can absorb an annual membership fee
Price is where Collective scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Collective (collective.org) is a membership-based telehealth platform from the founder of Thrive Market, selling compounded semaglutide and tirzepatide at a flat price on every dose. Medication is billed separately from a required annual membership, and the program bundles unlimited clinician messaging, dietitian access and express cold shipping.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Collective
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Collective at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $59/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Collective
Each dimension is scored algorithmically from Collective’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
9.9/10At $59/mo, Collective runs about 65% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.7/10Collective offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.7/10Online intake and platform experience — consult included in the price; 3 platform features disclosed.
Trust & Safety15%
7.9/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-18).
Accessibility10%
6.7/10Collective's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.5/10Collective provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Collective review
Last checked August 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Collective
We walked Collective’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Choose semaglutide or tirzepatide from the weight-loss page.
- 2Open the pre-qualification form (the medication is passed as a URL parameter).
- 3Complete the medical pre-qualification questionnaire.
- 4Join the Collective membership — 21-day free trial, then $199/year.
- 5A licensed provider reviews eligibility and prescribes if appropriate.
- Both medication prices are published before any intake, on the homepage and the weight-loss page.
- The $199 annual membership is disclosed in the FAQ copy rather than beside the headline price, so a reader who stops at '$59/month' will understate the real cost.
- The pre-qualification form itself displays no prices.
- We stopped at the questionnaire and did not create an account or pay.
GLP-1 medications Collective offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Verbatim: 'Compounded Semaglutide: $59/month. Same price, every dose. Cancel anytime.' ⛔ EXCLUDES the required membership — the site states 'What does it cost? $59/month + $199 annual membership.' First-year total is $907 ($75.58/mo equivalent).
Verbatim: 'Compounded Tirzepatide: $69/month. Same price, any dose.' ⛔ EXCLUDES the required membership — 'The cost is $69/month + $199 annual membership.' First-year total is $1,027 ($85.58/mo equivalent).
Verbatim: 'Requires Collective membership: 21 day free trial, then a low annual $199 membership fee. No recurring monthly membership charges.' Charged yearly, not monthly. Terms of Use: 'all membership fees are non-refundable, and partial-period refunds are not provided.'
Ready to get started?
Plans and promotions change often — check Collective's current pricing and active discounts before you decide.
What we like
- The lowest published compounded GLP-1 medication prices we track — $59/month semaglutide and $69/month tirzepatide
- Flat pricing at every dose, so titrating up does not raise the bill
- Unlimited clinician messaging and registered-dietitian access are included rather than upsold
- 21-day free trial on the membership before the annual fee is charged
Watch-outs
- The advertised $59 and $69 exclude a mandatory $199 annual membership — the real first-year cost is $907 and $1,027
- Membership fees are non-refundable and no partial-period refunds are given
- Compounding pharmacies are described only as 'independent, third-party licensed pharmacies' and are never named
- State availability is not published on the marketing site
Collective in one line: the cheapest medication price we track, with a membership fee attached
Collective sells compounded semaglutide at $59 a month and compounded tirzepatide at $69 — the lowest published medication prices in our directory, by a wide margin. It comes from the founder of Thrive Market and runs on the same idea: pool the buying power of a membership base, then sell close to cost. The catch is right there in the model. The membership is not optional, and the headline price does not include it.
What it actually costs — read this before you compare it to anything
The advertised numbers are real, and they are only part of the bill. Collective's own FAQ states it plainly: the cost is $59 a month plus a $199 annual membership. There is a 21-day free trial on the membership, and after that it renews yearly rather than monthly — the site is explicit that there are no recurring monthly membership charges. So the real yearly cost is twelve months of medication plus $199 — which works out to roughly a third more per month than the sticker price suggests.
Even with the membership folded in, Collective lands dramatically below the category median of about $169 a month. We are not flagging the membership because it makes the deal bad — it doesn't. We're flagging it because a reader who sees "$59/month" and stops there will budget a third low, and because the membership fee is non-refundable under Collective's own terms. Plan to stay at least a year, or the annual fee stops being good value.
- Semaglutide: $59/month for the medication, any dose
- Tirzepatide: $69/month for the medication, any dose
- Membership: $199/year, required, after a 21-day free trial
- Budget on: twelve medication payments plus one $199 membership charge
What the membership buys beyond the discount
This is not a bare medication mill. The membership includes unlimited messaging with the clinical team and free access to registered dietitians — support that most providers either omit or sell as a separate coaching tier. Shipping is 2-day express and cold-chain, the products are described as third-party tested, and the whole program is HSA/FSA eligible. Pricing is flat at every dose, so titrating from a starting dose up to a maintenance dose does not change what you pay.
The nutrition and lifestyle layer is the part worth weighing. GLP-1 outcomes are better when the medication sits inside a real behavior-change program, and Collective bundles that rather than charging for it. If you would otherwise pay separately for a dietitian, the membership fee starts looking less like a surcharge and more like the thing you were going to buy anyway.
Where the disclosure falls short
Collective's terms describe prescriptions as dispensed "solely by independent, third-party licensed pharmacies" — and never name one. For a compounded product that is a real gap. The pharmacy is the entity actually making your medication, and naming it is the single clearest signal a compounded seller can give. Providers we rate higher on trust name theirs outright. Collective also doesn't publish a state-availability list, so you'll only learn whether it serves your state by starting the pre-qualification.
The corporate structure is disclosed properly, at least: the operating entity is Health For Everyone Inc., doing business as CollectiveOS, and the terms are clear that it is a technology platform rather than a medical provider — the clinicians and pharmacies are independent third parties. That is the standard telehealth arrangement, honestly stated. We found no FDA warning letters against the entity or either trading name.
Who should choose Collective — and who should walk
Choose it if you intend to stay on a GLP-1 for a year or more and you want the lowest defensible total cost. Even counting the membership, nothing else we track comes close on a full year of semaglutide, and the included dietitian access is a genuine extra rather than a marketing line. The flat-at-every-dose pricing also means the maintenance phase costs the same as the start, which is where per-dose pricing quietly punishes people.
Skip it if you want to try a GLP-1 for a month or two and reassess — the annual fee is non-refundable and front-loads a commitment the medication pricing doesn't. Skip it too if a named compounding pharmacy is non-negotiable for you, or if you need brand-name Wegovy or Zepbound, which Collective does not sell.
Bottom line
Collective is the cheapest way we know of to stay on a compounded GLP-1, and the price is real — but the advertised figure is not the whole bill, and you should compare it on a full year including the membership rather than on $59 a month. Bundled clinician messaging and dietitian access are unusually generous at this price. The unnamed pharmacy and the unpublished state list are the two things keeping it off our top tier. Commit for a year and it is an excellent deal; treat it as a trial and the membership works against you.
Worth pricing against Sunlight ($88/month) before you commit — it's among the nearest alternatives to Collective.
The Bottom Line
Price is where Collective scores best in our breakdown.
Ready to start with Collective?
Starting at $59/month. See current pricing and start your free consultation.
Collective might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Collective review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Collective's current pricing
Plans start at $59/month. Start your free consultation to check eligibility and today's price.